Genmab — November 2018

[jkj]

sydbank q3https://data.sydbank.dk/api/investment/sydbank/publications/file/90360

[mobbyduck1]

tak for link, lidt betryggende at de har 2,055 mia $ i salg af darzalex i 2018

[jkj]

Siden findes ikke

(borsen.dk)

[jkj]

Godmorgen

[bibob]

Børsen https://borsen.dk/nyheder/avisen/artikel/11/211951/artikel.html?utm_source=forside&utm_campaign=nyhed_04

[bibob]

God morgen :-). jkj

[StockBull]

God morgen

[StockBull]

Sydbanks reviderede tal for ligner sådan set JMP's tal JPM omsætning SB JPM 4180. JPM profit 2173, SB 2324. JPM eps: 35.5.

[StockBull]

for 2019

[jkj]

https://penge.borsen.dk/artikel/1/372183/valuta_dollar_holder_fast_taet_paa_16_maaneders_hoejdepunkt.html

[StockBull]

4192 / 4180 og 2173 / 2324

[StockBull]

Så med samme PE for 2019 som vi har nu er der da kurs potentiale til 1400

[Plimsoller]

God morgen

[polle1]

God morgen, og god dag

[peter12]

Udmærket ældre artikel http://inrater.com/genmab-takeover-eller-uptake/

[E_L]

competitor article on GSK2857916 anti-BCMA in The Lancet http://sci-hub.tw/http://www.sciencedirect.com/science/article/pii/S147020451830576X

[StockBull]

Så Darzalex er alene 2200 ved 10bn usd i dara salg

[jkj]

https://www.nordnet.dk/mux/web/analys/nyheter/nyheterPressmeddelanden.html

[Bulder]

Tx E L. Still not a competitor in the early lines. And a possible combo partner in later lines.

[E_L]

yes, agree. it is not the same but also for JNJ BCMAxCD3 "Pre-treatment with dara was found to enhance the efficacy of JNJ-957 ". http://www.multiplemyelomahub.com/medical-information/eha-2018-preclinical-data-for-bcmaxcd3-bi-specific-antibody-jnj-957